Dashboard
Manage Tickers

MXLMAXLINEAR, INC

Nasdaq maxlinear.com


$ 14.08 $ -0.13 (-0.91 %)    

Wednesday, 18-Sep-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ 14.09
$ 14.31
$ 14.09 x 100
$ 14.11 x 200
$ 14.06 - $ 14.82
$ 11.08 - $ 26.59
604,497
na
1.18B
$ 1.66
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-24-2024 06-30-2024 10-Q
2 04-24-2024 03-31-2024 10-Q
3 01-31-2024 12-31-2023 10-K
4 10-25-2023 09-30-2023 10-Q
5 07-27-2023 06-30-2023 10-Q
6 04-26-2023 03-31-2023 10-Q
7 02-01-2023 12-31-2022 10-K
8 10-25-2022 09-30-2022 10-Q
9 07-27-2022 06-30-2022 10-Q
10 04-27-2022 03-31-2022 10-Q
11 02-02-2022 12-31-2021 10-K
12 10-27-2021 09-30-2021 10-Q
13 07-28-2021 06-30-2021 10-Q
14 04-28-2021 03-31-2021 10-Q
15 02-11-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 07-23-2020 06-30-2020 10-Q
18 04-29-2020 03-31-2020 10-Q
19 02-05-2020 12-31-2019 10-K
20 10-25-2019 09-30-2019 10-Q
21 07-25-2019 06-30-2019 10-Q
22 05-01-2019 03-31-2019 10-Q
23 02-05-2019 12-31-2018 10-K
24 10-30-2018 09-30-2018 10-Q
25 08-07-2018 06-30-2018 10-Q
26 05-09-2018 03-31-2018 10-Q
27 02-20-2018 12-31-2017 10-K
28 11-07-2017 09-30-2017 10-Q
29 08-08-2017 06-30-2017 10-Q
30 05-09-2017 03-31-2017 10-Q
31 02-09-2017 12-31-2016 10-K
32 11-07-2016 09-30-2016 10-Q
33 08-08-2016 06-30-2016 10-Q
34 05-09-2016 03-31-2016 10-Q
35 02-17-2016 12-31-2015 10-K
36 11-04-2015 09-30-2015 10-Q
37 08-10-2015 06-30-2015 10-Q
38 05-06-2015 03-31-2015 10-Q
39 02-23-2015 12-31-2014 10-K
40 10-30-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

on-semiconductor-posts-upbeat-earnings-joins-oil-states-international-commscope-holding-and-other-big-stocks-moving-higher-on-monday
ON Semiconductor Posts Upbeat Earnings, Jo...
07/29/2024 15:09:55

gold-down-25-northrop-grumman-posts-upbeat-earnings
Gold Down 2.5%; Northrop Grumman Posts Upb...
07/25/2024 18:23:10

why-edwards-lifesciences-shares-are-trading-lower-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Edwards Lifesciences Shares Are Tradin...
07/25/2024 18:12:27

maxlinear-analysts-cut-their-forecasts-after-q2-loss
MaxLinear Analysts Cut Their Forecasts Aft...
07/25/2024 17:53:44

northland-capital-markets-maintains-outperform-on-maxlinear-lowers-price-target-to-25
Northland Capital Markets Maintains Outper...
07/25/2024 17:46:05

Northland Capital Markets analyst Tim Savageaux maintains MaxLinear (NASDAQ:MXL) with a Outperform and lowers the price targ...

craig-hallum-maintains-hold-on-maxlinear-lowers-price-target-to-28
Craig-Hallum Maintains Hold on MaxLinear, ...
07/25/2024 16:07:01

Craig-Hallum analyst Richard Shannon maintains MaxLinear (NASDAQ:MXL) with a Hold and lowers the price target from $38 to $28.

this-lululemon-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-thursday
This Lululemon Analyst Is No Longer Bullis...
07/25/2024 14:48:24

ford-posts-downbeat-earnings-joins-maxlinear-stmicroelectronics-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Ford Posts Downbeat Earnings, Joins MaxLin...
07/25/2024 13:12:01

Core News & Articles
Market-Moving News for July 25th
07/25/2024 13:01:55

EW: -24% | Edwards Lifesciences shares are trading lower after the company reported worse-than-expected Q2 sales results and is...

susquehanna-maintains-positive-on-maxlinear-lowers-price-target-to-26
Susquehanna Maintains Positive on MaxLinea...
07/25/2024 12:34:30

Susquehanna analyst Christopher Rolland maintains MaxLinear (NASDAQ:MXL) with a Positive and lowers the price target from $3...

benchmark-maintains-buy-on-maxlinear-lowers-price-target-to-22
Benchmark Maintains Buy on MaxLinear, Lowe...
07/25/2024 11:53:06

Benchmark analyst David Williams maintains MaxLinear (NASDAQ:MXL) with a Buy and lowers the price target from $28 to $22.

needham-downgrades-maxlinear-to-hold
Needham Downgrades MaxLinear to Hold
07/25/2024 11:32:08

Needham analyst Quinn Bolton downgrades MaxLinear (NASDAQ:MXL) from Buy to Hold.

why-indivior-shares-are-trading-higher-here-are-20-stocks-moving-premarket
Why Indivior Shares Are Trading Higher; He...
07/25/2024 10:36:30

maxlinear-sees-q3-revenue-70m-90m-vs-100044m-est
MaxLinear Sees Q3 Revenue $70M-$90M Vs $10...
07/24/2024 20:40:42

maxlinear-q2-2024-adj-eps-025-misses-019-estimate-sales-91990m-miss-100044m-estimate
MaxLinear Q2 2024 Adj EPS $(0.25) Misses $...
07/24/2024 20:27:06

MaxLinear (NASDAQ:MXL) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.19) by...

stifel-maintains-buy-on-maxlinear-raises-price-target-to-30
Stifel Maintains Buy on MaxLinear, Raises ...
07/18/2024 15:43:07

Stifel analyst Tore Svanberg maintains MaxLinear (NASDAQ:MXL) with a Buy and raises the price target from $26 to $30.

susquehanna-maintains-positive-on-maxlinear-raises-price-target-to-30
Susquehanna Maintains Positive on MaxLinea...
07/17/2024 13:10:40

Susquehanna analyst Christopher Rolland maintains MaxLinear (NASDAQ:MXL) with a Positive and raises the price target from $2...

peeling-back-the-layers-exploring-maxlinear-through-analyst-insights
Peeling Back The Layers: Exploring MaxLine...
07/09/2024 14:01:18

benchmark-reiterates-buy-on-maxlinear-maintains-28-price-target
Benchmark Reiterates Buy on MaxLinear, Mai...
07/09/2024 12:29:09

Benchmark analyst David Williams reiterates MaxLinear (NASDAQ:MXL) with a Buy and maintains $28 price target.

benchmark-reiterates-buy-on-maxlinear-maintains-28-price-target
Benchmark Reiterates Buy on MaxLinear, Mai...
04/25/2024 15:03:48

Benchmark analyst David Williams reiterates MaxLinear (NASDAQ:MXL) with a Buy and maintains $28 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION